In a Phase I trial, what must be verified first before administering the investigational agent?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the CPHON Chemotherapy Test with interactive materials. Use flashcards and multiple choice questions with hints and explanations. Get exam-ready!

Multiple Choice

In a Phase I trial, what must be verified first before administering the investigational agent?

Explanation:
Before giving any investigational drug in a Phase I trial, informed consent must be obtained and documented. This ensures the patient fully understands the study, including risks, potential benefits, alternatives, and the right to withdraw, and confirms that participation is voluntary. Without valid informed consent, no trial procedures or dosing should proceed, regardless of other preparatory steps. While baseline labs, eligibility criteria, or protocol-specific consents (like transfusion) may be required, they do not replace the fundamental need for informed consent.

Before giving any investigational drug in a Phase I trial, informed consent must be obtained and documented. This ensures the patient fully understands the study, including risks, potential benefits, alternatives, and the right to withdraw, and confirms that participation is voluntary. Without valid informed consent, no trial procedures or dosing should proceed, regardless of other preparatory steps. While baseline labs, eligibility criteria, or protocol-specific consents (like transfusion) may be required, they do not replace the fundamental need for informed consent.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy